Insider Holders & Insider Ownership - AMICUS THERAPEUTICS INC. (FOLD)

List of insiders holdings for AMICUS THERAPEUTICS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
2024-02-14 16:38:2828,057,456
0
28,057,456Form 13G
Redmile Group LLC
Green Jeremy
10% Owner
2024-02-14 16:26:2221,957,926
0
21,957,926Form 13G
PERRY MARK W
10% Owner
2012-03-09 15:52:380
4,584,311
4,584,311Form 4
NEW ENTERPRISE ASSOCIATES 11 LP
NEA PARTNERS 11 LP
NEA 11 GP LLC
BASKETT FOREST
DRANT RYAN D
KOLLURI KRISHNA KITTU
SANDELL SCOTT D
10% Owner
2012-03-09 15:55:054,584,311
0
4,584,311Form 4
BARRIS PETER J
10% Owner
2012-03-09 15:54:270
4,584,311
4,584,311Form 4
KRAMLICH C RICHARD
10% Owner
2012-03-09 15:53:360
4,584,311
4,584,311Form 4
NEWHALL CHARLES W III
10% Owner
2012-03-09 15:52:560
4,584,311
4,584,311Form 4
CHL Medical Partners II Side Fund L.P.
10% Owner
2007-06-07 13:58:162,108,555
1,975,456
4,084,011Form 4
NEW ENTERPRISE ASSOCIATES 11 LP
NEA PARTNERS 11 LP
NEA 11 GP LLC
BARRETT M JAMES
BASKETT FOREST
DRANT RYAN D
KOLLURI KRISHNA KITTU
LINEHAN CHARLES M
SANDELL SCOTT D
TRAINOR III EUGENE A
10% Owner
2007-06-07 20:28:233,659,157
0
3,659,157Form 4
Garden State Life Sciences Venture Fund L P
10% Owner
2007-06-07 10:41:251,419,762
1,064,822
2,484,584Form 4
PROSPECT VENTURE PARTNERS II LP
PROSPECT ASSOCIATES II L P
PROSPECT MANAGEMENT CO II LLC
TANANBAUM JAMES B
SCHNELL DAVID
HIRSCH RUSSELL C
10% Owner
2013-01-28 17:13:592,240,752
0
2,240,752Form 13G
QUAKER BIO VENTURES LP
10% Owner
2012-02-14 14:33:031,429,762
0
1,429,762Form 13G
CHL Medical Partners II L.P.
10% Owner
2010-02-05 14:33:551,365,941
0
1,365,941Form 13G
Campbell Bradley L
President and CEO
2024-05-03 17:21:26939,154
0
939,154Form 4
Crowley John F
Executive Chairman
2024-03-15 19:14:06927,013
0
927,013Form 4/A
Canaan Equity Partners III LLC
CANAAN EQUITY III LP
CANAAN EQUITY III ENTREPRENEURS LLC
BALEN JOHN V
GREEN L STEPHEN
DEEPAK KAMRA
KOPCHINSKY GREGORY
RUDNICK SETH
RUSSO GUY M
YOUNG ERIC A
10% Owner
2010-02-10 16:10:48552,191
0
552,191Form 13G
Do Hung
Chief Science Officer
2021-04-08 20:05:06448,617
0
448,617Form 4
Quimi Daphne
Chief Financial Officer
2023-01-19 18:16:09398,532
0
398,532Form 4
Rosenberg Ellen
Chief Legal Officer
2024-03-15 19:10:32384,219
0
384,219Form 4/A
Castelli Jeff
Chief Development Officer
2024-03-15 19:12:03377,205
0
377,205Form 4/A
Clark David Michael
Chief People Officer
2024-03-15 19:13:16271,775
0
271,775Form 4/A
Harford Simon N.R.
Chief Financial Officer
2024-01-04 18:17:02263,438
0
263,438Form 4
Barth Jay
Chief Medical Officer
2020-10-02 16:34:33177,870
20
177,890Form 4
Dilone Enrique
SVP, Technical Operations
2015-06-23 20:09:25158,598
0
158,598Form 4
LOVE TED W
Director
2020-06-08 16:57:03149,574
0
149,574Form 4
Baird William D III
Chief Financial Officer
2018-10-17 18:28:05141,622
0
141,622Form 4
Weinhoff Gregory M
Director
2008-08-18 16:05:370
129,943
129,943Form 4
WHITMAN BURKE W
Director
2023-06-12 17:36:11116,811
0
116,811Form 4
Bleil Lynn Dorsey
Director
2023-06-12 17:39:11112,154
0
112,154Form 4
Ludwig Karin
Senior VP, Clinical Research
2007-05-30 19:56:54106,667
0
106,667Form 3
Patterson Matthew R
Acting CEO & President
2011-04-19 15:53:18106,547
0
106,547Form 4
Lockhart David J
Chief Scientific Officer
2013-06-20 16:10:15100,000
0
100,000Form 4
Gershkowitz Jayne
SVP, Chief Patient Advocate
2015-07-01 17:27:0999,396
0
99,396Form 4
Andrews Kurt J.
SVP, Human Resources
2018-07-05 16:25:3990,469
0
90,469Form 4
SBLENDORIO GLENN
Director
2024-03-11 17:36:2983,596
0
83,596Form 4
RAAB MICHAEL
Director
2024-03-06 17:22:1783,596
0
83,596Form 4
WHEELER CRAIG A
Director
2023-06-12 17:35:0582,844
0
82,844Form 4
Boudes Pol F
Chief Medical Officer
2012-06-06 16:44:0480,000
0
80,000Form 4
Baldry Mark
VP Global Marketing
2015-06-04 18:56:3975,000
0
75,000Form 4
ROBERTS EIRY
Director
2023-06-12 17:38:0274,488
0
74,488Form 4
Prout Samantha
Chief Accounting Officer
2024-04-16 17:42:2073,926
0
73,926Form 4
Valenzano Ken
SVP, Pharmacology & Biology
2015-07-15 17:05:4871,687
0
71,687Form 4
Kelly Michael Aaron
Director
2023-06-12 17:40:1370,681
0
70,681Form 4
ESSNER ROBERT
Director
2021-06-14 19:14:0667,226
0
67,226Form 4
MCGLYNN MARGARET G
Director
2024-03-06 17:21:1266,789
0
66,789Form 4
Peist Kenneth
VP, Legal & IP
2016-01-06 16:18:2563,874
0
63,874Form 4
Simon Mark
Sr. VP, Business Development
2007-05-30 19:52:1963,334
0
63,334Form 3
Bloch Stephen M
Director
2009-02-12 13:31:120
61,700
61,700Form 4
David Allsop
SVP International
2015-04-28 17:01:4350,000
0
50,000Form 4
Kirk John
VP, Regulatory Affairs
2015-06-03 19:18:5845,000
0
45,000Form 4
Schaeffer Orlov S Nicole
SVP, HR & Leadership Devt
2012-02-17 14:38:2845,000
0
45,000Form 4
Branch Douglas A
VP, General Counsel & Sec.
2007-05-30 19:47:2840,002
0
40,002Form 3
Winterbottom Joan
SVP, Human Resources
2013-06-20 16:11:1140,000
0
40,000Form 4
Macaluso Peter M
VP & Corporate Counsel
2013-06-20 16:12:2135,000
0
35,000Form 4
Winkler Robert E
VP, Clin Research & Operations
2012-06-06 16:48:1235,000
0
35,000Form 4
Palling David
Sr VP, Technical Operations
2009-06-30 12:53:5134,040
0
34,040Form 4
Dentzer James E
Chief Financial Officer
2009-10-01 13:49:1332,075
0
32,075Form 4
Licholai Gregory P
VP, Medical Affairs
2009-02-05 12:02:5427,000
0
27,000Form 4
BARER SOL J
Director
2016-06-13 14:37:4420,000
0
20,000Form 4
Shenker Andrew
VP, Clinical Research
2009-02-05 12:16:1018,000
0
18,000Form 4
HAYDEN DONALD J JR
Director
2018-06-11 16:44:5917,807
0
17,807Form 4
John McAdam M
VP, Finance & Accounting
2010-06-17 11:48:3515,000
0
15,000Form 4
Topper James N
Director
2014-06-16 12:50:4515,000
0
15,000Form 4
BARRETT M JAMES
Director
10% Owner
2014-06-16 11:35:1615,000
0
15,000Form 4
Doshi Dipal
SVP Strategy & Bus Dev
2015-07-09 18:26:3514,206
0
14,206Form 4
BARKAS ALEXANDER E
Director
2011-06-14 14:42:2610000
0
10000Form 4
NEFF P SHERRILL
Director
2010-06-17 09:52:5410000
0
10000Form 4
Gilmore Geoffrey
SVP & General Counsel
2012-03-13 13:28:0610000
0
10000Form 4
GLAXOSMITHKLINE PLC
Former 10% Owner (1)
2014-10-28 14:35:360
0
0Form 4
Yu Julie
VP Clinical Ops & Data Mgmt
2015-06-16 20:14:590
0
0Form 4
FHM IV LP
Frazier Healthcare V LP
FHM V LP
FHM V LLC
FRAZIER HEALTHCARE IV LP
FRAZIER AFFILIATES IV LP
10% Owner
2016-03-08 14:35:340
0
0Form 13G
Mount Sinai School of Medicine of New York University
10% Owner
2007-06-07 15:44:370
0
0Form 4